We thank Dr. Li et al. for their letter
1
regarding our publication.2
During the design of a randomized clinical trial, defining what constitutes a minimal clinically importance difference (MCID) for opioid reduction is not always straightforward as opioid consumption may be influenced by gender, body mass index, preoperative pain, genetics, and metabolism.3
Although there is very little data to determine the MCID for many outcomes,4
including opioid consumption,3
28% recurs frequently. As an example, a recent publication that aimed to determine the MCID for morphine milligram equivalents (MMEs) in patients with failed back surgery syndrome concluded the MCID was 28.2% for MMEs.5
Similarly, in a widely respected and frequently cited investigation, Farrar et al. concluded that a decrease in pain greater than or equal to 28% was clinically significant.6
Thus, we chose to power for a 30% opioid reduction based on a quality review of the perioperative care for 10 hip arthroscopy patients. Notably, postoperative opioid consumption was reduced 28.3% in the block group in our study.2
Additionally, while an absolute decrease of 10 mg intravenous morphine over 24 hours (∼2.4 mg/hour) was recently proposed as a clinician-perceived MCID estimate for lower extremity arthroplasty,7
our data and postoperative opioid consumption were only collected over approximately 1.5 hours (∼2.1 mg/hour). Last, Dr. Li et al. suggest that our patients may have had inadequate pain relief as their VAS scores were greater than 30 on discharge. All patients were provided opioids in recovery until they determined that their pain control was adequate for home discharge; only then did they make their final pain rating. Although we excluded patients taking opioids for more than 3 months preoperatively, most of our patients had preoperative pain, were already taking multimodal analgesics, including opioids, and reported pain scores exceeding 30 in the preoperative holding area prior to surgery. Therefore, after an extensive operative procedure and repair, it is not unreasonable to expect their pain to be greater at discharge than on arrival.Supplementary Data
- ICMJE author disclosure forms
References
- Regarding “Preoperative Quadratus Lumborum Block Reduces Opioid Requirements in the Immediate Postoperative Period Following Hip Arthroscopy: A Randomized, Blinded Clinical Trial”.Arthroscopy. 2022; 38: 2365-2366
- Preoperative quadratus lumborum block reduces opioid requirements in the immediate postoperative period following hip arthroscopy: A randomized, blinded clinical trial.Arthroscopy. 2022; 38: 808-815
- Why science is less scientific than we think (and what to do about it): The 2022 Gaston Labat Award Lecture.Reg Anesth Pain Med. 2022; 47: 395-400
- Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on methods, measurement, and pain assessment in clinical trials recommendations.Pain. 2021; 162: 2669-2681
- Determining the minimal clinical important difference for medication quantification scale III and morphine milligram equivalents in patients with failed back surgery syndrome.J Clin Med. 2020; 9: 3747
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.Pain. 2001; 94: 149-158
- Minimal clinically important differences in randomised clinical trials on pain management after total hip and knee arthroplasty: A systematic review.Br J Anaesth. 2021; 126: 1029-1037
Article info
Footnotes
Note: Full ICMJE author disclosure forms are available for this article online, as supplementary material.
Identification
Copyright
© 2022 by the Arthroscopy Association of North America
ScienceDirect
Access this article on ScienceDirectLinked Article
- Regarding “Preoperative Quadratus Lumborum Block Reduces Opioid Requirements in the Immediate Postoperative Period Following Hip Arthroscopy: A Randomized, Blinded Clinical Trial”ArthroscopyVol. 38Issue 8
- PreviewBy a randomized controlled trial with small sample of 46 patients undergoing hip arthroscopy, Wilson et al.1 assessed the effect of preoperative lateral quadratus lumborum block (LQLB) on opioid consumption for early postoperative pain control and showed that opioid consumption significantly decreased in the patients receiving the LQLB combined with a standardized multimodal analgesia protocol, as compared with patients not receiving a block. Given the facts that the use of multimodal analgesia protocol, including a nerve block can improve postoperative analgesia, and is being emphasized in current practice of Enhanced Recovery After Surgery protocols,2 this study has the potential implications.
- Full-Text
- Preview